Nachrichten zur Abbvie Inc. Aktie

AbbVie (ABBV) Gains As Market Dips: What You Should Know

The latest trading day saw AbbVie (ABBV) settling at $186.11, representing a +0.26% change from its previous close.…

Better Dividend Growth ETF: Vanguard Dividend Appreciation ETF or iShares Core Dividend Growth ETF

Dividend growth stocks can be powerful investments. Hartford Funds and Ned Davis Research dug into the data on stocks based…

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical

Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and strategic moves in new reports.…

CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CERE

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Elon Musk Commits to Tesla. Is That a Good Thing?

In this podcast, Motley Fool analyst Jason Moser and host Ricky Mulvey discuss: Investing in companies with a "singular" leader, like…

2 Incredible Dividend Growth Stocks to Buy Now

Dividend growth stocks have long been reliable engines of wealth creation. Historically, companies with 10-year annualized dividend growth rates above…

The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie

Bayer, Novo Nordisk, GSK, Merck and AbbVie are part of the Zacks top Analyst Blog.…

3 Magnificent Stocks That Are Passive Income Machines

Make money without even trying: Thats what passive income is all about. But good investment alternatives are required to make…

US FDA approves AbbVies drug for a type of lung cancer

The U.S. Food and Drug Administration has approved AbbVies drug to treat adults with a type of lung cancer who…

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

1 No-Brainer Dividend Index Fund to Buy Right Now for Less Than $500 -- and Another Dividend Fund Yielding 11%

Two of the best things in the investment world are index funds and dividend-paying stocks. So an even better thing,…

Recession Worries? Heres 1 of the Best Dividend Stocks for Turbulent Times

J.P. Morgan stated last month that it believes there is a 60% chance of a recession in 2025 due to…

2 High-Yield Dividend Stocks to Buy in May and Hold Forever

When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but…

AbbVie Aktie: Es läuft wie geschmiert

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt in…

Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now

The S&P 500 has bounced back somewhat after sinking nearly 19% below its previous high following President Trumps "Liberation Day"…

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns…

Why AbbVie Stock Trounced the Market Today

The positive, post-earnings momentum lifting AbbVies (NYSE: ABBV) stock price continued on Monday. The veteran healthcare companys shares booked a…

Want to Avoid the "Magnificent Seven" and Generate Passive Income? This Vanguard ETF May Be for You

The "Magnificent Seven" -- Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla -- took the market by storm in…

3 Dividend Stocks to Buy and Hold for the Next Decade

Many income investors would love to have a low-maintenance portfolio that doesnt require constant attention. Theyd prefer to buy great…

Should Investors Be Worried About Dividend King AbbVie?

Nearly everything looked great with AbbVies (NYSE: ABBV) first-quarter results. The big drugmakers revenue jumped 8.4% year over year, thanks…

Medikamentenumsätze höher als erwartet! AbbVie legt kräftig zu und erhöht Gewinnprognose für 2025!

Das Pharmaunternehmen AbbVie (ABBV) hat am Freitag, den 25. April 2025, vor Börsenbeginn seine Geschäftszahlen für das 1. Quartal 2025…

Why AbbVies Stock Is A Strong Buy After Q1 2025 Results

…

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

Its always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a…

2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

Many investors are withdrawing their money from the stock market right now, but those focused on the long term know…

Why AbbVie Stock Topped the Market Today

A pair of convincing quarterly earnings beats -- not to mention a profitability guidance raise -- made AbbVie (NYSE: ABBV)…

AbbVies First Quarter Beat And Raise Leaves Room For More

…

AbbVie: Q1 Earnings Reinforce Positive Momentum

…

AbbVie Beats on Q1 Earnings & Sales, Raises 25 EPS View

ABBVs first-quarter earnings and sales beat estimates. The company raises its EPS guidance based on the strong sales performance of…

Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

AbbVie Aktie: Starkes Q1 dank Skyrizi und Rinvoq

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt in…

AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast By Investing.com

AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast…

AbbVie: Einbruch bei Humira um 51 Prozent – darum steigt die Dividenden-Aktie trotzdem

Der Pharma-Riese AbbVie muss bei seinem einstigen Top-Seller Humira kräftige Einbußen hinnehmen. Dafür glänzt das Unternehmen mit dem Wachstum bei…

AbbVie: Einbruch bei Humira um 51 Prozent – darum steigt die Dividenden-Aktie trotzdem

Der Pharma-Riese AbbVie muss bei seinem einstigen Top-Seller Humira kräftige Einbußen hinnehmen. Dafür glänzt das Unternehmen mit dem Wachstum bei…

AbbVie lifts profit forecast on strong sales of newer immunology drugs

AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped…

AbbVie lifts guidance as Q1 results top expectations

Abbvie Inc (NYSE:ABBV) shares moved higher after it reported strong results for the first quarter of 2025 and raised its full-year…

AbbVie Aktie: Zwischen Hoffnung und Skepsis

AbbVie-Aktie legt zu, doch Experten bewerten unterschiedlich. Neue Medikamente sollen Humira-Verluste ausgleichen. Bleibt die Erwartungshaltung realistisch? Analysten gespaltenAnzeigeSollten Anlege...…

Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA

The medical sector can provide a defensive hedge against economic uncertainty, and investors may be eyeing AbbVie (ABBV) and HCA…

2 High-Yield Dividend Stocks to Buy for Passive Income

Passive income is essential in retirement, but building a dependable stream isnt easy. Fortunately, top-tier dividend stocks can do the…

Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings

Investors will likely focus on the sales performance of AbbVies blockbuster immunology drugs, Rinvoq and Skyrizi, when it reports Q1…

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…

AbbVie (ABBV) Stock Moves -1.64%: What You Should Know

In the closing of the recent trading day, AbbVie (ABBV) stood at $170.16, denoting a -1.64% change from the preceding…

The Best Value ETF to Invest $500 in Right Now

Lets say you have $500 to invest and youre wondering where to park it. Thats a great position to be…

AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

AbbVie (ABBV) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Top Research Reports for AbbVie, TJX & Charles Schwab

Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc. (TJX)…

The Zacks Analyst Blog Merck and AbbVie

Merck and AbbVie are included in this Analyst Blog.…

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Investing $60,000 in These 3 Funds Could Generate Annual Income of Over $6,500

Income investors could pay attention to the price fluctuations of the assets they own. But they dont have to. What…

Under-the-radar drug stock has big rebound potential here despite turmoil, says Carter Worth

Carter breaks down the charts on large-cap pharmaceutical manufacturer AbbVie.…

The Last Time the Stock Market Started a Year This Badly Was 2022. Is Another Crash Coming?

As of Mondays close, the S&P 500 has fallen by about 15% this year (although the index regained about half…

Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more

These are the stocks posting the largest moves in midday trading.…